Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

241.34
Delayed Data
As of Mar 29
 +0.81 / +0.34%
Today’s Change
184.50
Today|||52-Week Range
277.96
+14.92%
Year-to-Date
Buoyant Biotechs
Mar 29 / TheStreet.com - Paid Partner Content
Impax Gains 38% On CEO Appointment, Talk of Sale
Mar 27 / TheStreet.com - Paid Partner Content
Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, ...
Mar 29 / GuruFocus News - Paid Partner Content
Has Allergan's Pullback Ended?
Mar 27 / TheStreet.com - Paid Partner Content
Allergan Acne Candidate Meets Endpoints in Phase III Studies
Mar 28 / Zacks.com - Paid Partner Content
Here's What I'm Doing With AGN, LNC and MET
Mar 27 / TheStreet.com - Paid Partner Content
Reviewing the Large-Cap Fave Troops
Mar 28 / TheStreet.com - Paid Partner Content
Skincare Makers Lead Biotech Movers
Mar 27 / TheStreet.com - Paid Partner Content
Risk-Reward With Teva Pharmaceutical
Mar 27 / GuruFocus News - Paid Partner Content
Can This Pharma Stock Withstand the 'Trump Effect'?
Mar 25 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close240.53
Today’s open240.61
Day’s range240.45 - 243.06
Volume2,233,778
Average volume (3 months)4,011,141
Market cap$80.7B
Dividend yield1.16%
Data as of 4:00pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+18.72%
Earnings growth (next 5 years)+10.50%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book1.13

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.04-0.13%
ABTAbbott Laboratories-0.03-0.07%
BMYBristol-Myers Squibb-0.25-0.44%
LLYEli Lilly and Co-0.31-0.37%
Data as of 4:02pm ET, 03/29/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$3.39
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs